The therapeutic effects of camel milk and chicory inulin in autistic childre

Phase 2

• Conditions: Autism spectrum disorder.; Autistic disorder; F84.0

• Registration Number: IRCT20181227042147N1
• Lead Sponsor: Mashhad University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 26 August 2019

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 99

Inclusion Criteria

children with DSM 5 diagnosis of autism
Ages between 3 and 15 years old

Exclusion Criteria

History of allergy to camel milk or chicory Inulin
Chronic Infectious Diseases or AIDS
Organic diseases
Other Psychiatric and neurological disorders (for example: epilepsy, seizure, syndromes, ...)
consuming camel milk
consuming pre/probiotics’ products

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Autism disorder Severity. Timepoint: At baseline and after 7 weeks of intervention. Method of measurement: Gilliam Autism Rating Scale-GARS- Questionnaire.;Evaluating the efficacy of treatment. Timepoint: At baseline and after 7 weeks of intervention. Method of measurement: Autism Treatment Evaluation Checklist (ATEC).

Secondary Outcome Measures

Name	Time	Method
Superoxide Dismutase (SOD) activity. Timepoint: At baseline and end of intervention (after 7 weeks). Method of measurement: Spectrophotometry.;Total thiols concentration. Timepoint: At baseline and end of intervention (after 7 weeks). Method of measurement: Spectrophotometry.;Catalase activity. Timepoint: At baseline and end of intervention (after 7 weeks). Method of measurement: Spectrophotometry.;Malondialdehyde (MDA). Timepoint: At baseline and end of intervention (after 7 weeks). Method of measurement: Spectrophotometry.